(DKNG) DraftKings - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US26142V1052
Stock: Sports Betting, Fantasy Sports, iGaming, Retail Sportsbooks, NFTs
Total Rating 17
Risk 40
Buy Signal -1.36
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 57.2% |
| Relative Tail Risk | -0.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.76 |
| Alpha | -54.63 |
| Character TTM | |
|---|---|
| Beta | 1.174 |
| Beta Downside | 1.401 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.29% |
| CAGR/Max DD | 0.36 |
Description: DKNG DraftKings December 19, 2025
DraftKings Inc. (NASDAQ:DKNG) is a Boston-based digital sports entertainment platform that operates online sports betting, daily fantasy sports, iGaming (online casino games such as blackjack, roulette, baccarat, and slots), and a retail sportsbook network. The firm also licenses its betting-software to other operators and runs a digital collectibles marketplace that sells curated NFTs.
Key recent metrics (Q3 2024): revenue of $1.04 billion (+19% YoY), monthly active customers up 12% to 4.8 million, and adjusted EBITDA margin of 9.5%. Growth is driven by continued state-level legalization of sports betting in the U.S., rising discretionary spend on online gaming, and expanding partnerships with media companies that boost brand visibility. The broader Casinos & Gaming sub-industry is benefiting from a projected $10 billion increase in U.S. betting handle through 2027, according to industry analysts.
If you want a deeper quantitative dive, ValueRay’s analyst tools provide granular forecasts and scenario modeling for DKNG’s earnings trajectory.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -267.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 11.23 > 1.0 |
| NWC/Revenue: 3.09% < 20% (prev -0.06%; Δ 3.15% < -1%) |
| CFO/TA 0.14 > 3% & CFO 667.6m > Net Income -267.6m |
| Net Debt (678.3m) to EBITDA (44.9m): 15.11 < 3 |
| Current Ratio: 1.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (529.5m) vs 12m ago 8.91% < -2% |
| Gross Margin: 47.57% > 18% (prev 0.38%; Δ 4719 % > 0.5%) |
| Asset Turnover: 122.7% > 50% (prev 107.8%; Δ 14.90% > 0%) |
| Interest Coverage Ratio: -6.01 > 6 (EBITDA TTM 44.9m / Interest Expense TTM 37.1m) |
Altman Z'' -6.50
| A: 0.04 (Total Current Assets 1.95b - Total Current Liabilities 1.78b) / Total Assets 4.62b |
| B: -1.42 (Retained Earnings -6.57b / Total Assets 4.62b) |
| C: -0.05 (EBIT TTM -222.7m / Avg Total Assets 4.45b) |
| D: -1.68 (Book Value of Equity -6.54b / Total Liabilities 3.89b) |
| Altman-Z'' Score: -6.50 = D |
Beneish M -4.00
| DSRI: 0.14 (Receivables 65.6m/406.2m, Revenue 5.46b/4.61b) |
| GMI: 0.81 (GM 47.57% / 38.50%) |
| AQI: 0.95 (AQ_t 0.55 / AQ_t-1 0.58) |
| SGI: 1.19 (Revenue 5.46b / 4.61b) |
| TATA: -0.20 (NI -267.6m - CFO 667.6m) / TA 4.62b) |
| Beneish M-Score: -4.02 (Cap -4..+1) = AAA |
What is the price of DKNG shares?
As of February 08, 2026, the stock is trading at USD 26.62 with a total of 16,116,937 shares traded.
Over the past week, the price has changed by -3.24%, over one month by -23.83%, over three months by -4.86% and over the past year by -37.28%.
Over the past week, the price has changed by -3.24%, over one month by -23.83%, over three months by -4.86% and over the past year by -37.28%.
Is DKNG a buy, sell or hold?
DraftKings has received a consensus analysts rating of 4.47.
Therefore, it is recommended to buy DKNG.
- StrongBuy: 20
- Buy: 7
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DKNG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 45.1 | 69.4% |
| Analysts Target Price | 45.1 | 69.4% |
| ValueRay Target Price | 26 | -2.4% |
DKNG Fundamental Data Overview February 03, 2026
P/E Forward = 17.452
P/S = 2.5089
P/B = 20.3518
Revenue TTM = 5.46b USD
EBIT TTM = -222.7m USD
EBITDA TTM = 44.9m USD
Long Term Debt = 1.84b USD (from longTermDebt, last quarter)
Short Term Debt = 11.5m USD (from shortTermDebt, last quarter)
Debt = 1.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 678.3m USD (from netDebt column, last quarter)
Enterprise Value = 14.37b USD (13.69b + Debt 1.91b - CCE 1.23b)
Interest Coverage Ratio = -6.01 (Ebit TTM -222.7m / Interest Expense TTM 37.1m)
EV/FCF = 23.22x (Enterprise Value 14.37b / FCF TTM 619.0m)
FCF Yield = 4.31% (FCF TTM 619.0m / Enterprise Value 14.37b)
FCF Margin = 11.34% (FCF TTM 619.0m / Revenue TTM 5.46b)
Net Margin = -4.90% (Net Income TTM -267.6m / Revenue TTM 5.46b)
Gross Margin = 47.57% ((Revenue TTM 5.46b - Cost of Revenue TTM 2.86b) / Revenue TTM)
Gross Margin QoQ = 71.27% (prev 43.50%)
Tobins Q-Ratio = 3.11 (Enterprise Value 14.37b / Total Assets 4.62b)
Interest Expense / Debt = 1.03% (Interest Expense 19.6m / Debt 1.91b)
Taxrate = 21.0% (US default 21%)
NOPAT = -175.9m (EBIT -222.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.09 (Total Current Assets 1.95b / Total Current Liabilities 1.78b)
Debt / Equity = 2.60 (Debt 1.91b / totalStockholderEquity, last quarter 732.3m)
Debt / EBITDA = 15.11 (Net Debt 678.3m / EBITDA 44.9m)
Debt / FCF = 1.10 (Net Debt 678.3m / FCF TTM 619.0m)
Total Stockholder Equity = 906.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -6.01% (Net Income -267.6m / Total Assets 4.62b)
RoE = -29.52% (Net Income TTM -267.6m / Total Stockholder Equity 906.4m)
RoCE = -8.12% (EBIT -222.7m / Capital Employed (Equity 906.4m + L.T.Debt 1.84b))
RoIC = -6.77% (negative operating profit) (NOPAT -175.9m / Invested Capital 2.60b)
WACC = 9.09% (E(13.69b)/V(15.60b) * Re(10.24%) + D(1.91b)/V(15.60b) * Rd(1.03%) * (1-Tc(0.21)))
Discount Rate = 10.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.36%
[DCF Debug] Terminal Value 65.45% ; FCFF base≈408.3m ; Y1≈268.0m ; Y5≈122.3m
Fair Price DCF = 2.68 (EV 2.01b - Net Debt 678.3m = Equity 1.33b / Shares 497.8m; r=9.09% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 77.75 | EPS CAGR: 40.30% | SUE: -0.57 | # QB: 0
Revenue Correlation: 91.07 | Revenue CAGR: 26.53% | SUE: -1.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.26 | Chg30d=-0.012 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=1.59 | Chg30d=-0.023 | Revisions Net=-2 | Growth EPS=+107.9% | Growth Revenue=+21.3%
P/S = 2.5089
P/B = 20.3518
Revenue TTM = 5.46b USD
EBIT TTM = -222.7m USD
EBITDA TTM = 44.9m USD
Long Term Debt = 1.84b USD (from longTermDebt, last quarter)
Short Term Debt = 11.5m USD (from shortTermDebt, last quarter)
Debt = 1.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 678.3m USD (from netDebt column, last quarter)
Enterprise Value = 14.37b USD (13.69b + Debt 1.91b - CCE 1.23b)
Interest Coverage Ratio = -6.01 (Ebit TTM -222.7m / Interest Expense TTM 37.1m)
EV/FCF = 23.22x (Enterprise Value 14.37b / FCF TTM 619.0m)
FCF Yield = 4.31% (FCF TTM 619.0m / Enterprise Value 14.37b)
FCF Margin = 11.34% (FCF TTM 619.0m / Revenue TTM 5.46b)
Net Margin = -4.90% (Net Income TTM -267.6m / Revenue TTM 5.46b)
Gross Margin = 47.57% ((Revenue TTM 5.46b - Cost of Revenue TTM 2.86b) / Revenue TTM)
Gross Margin QoQ = 71.27% (prev 43.50%)
Tobins Q-Ratio = 3.11 (Enterprise Value 14.37b / Total Assets 4.62b)
Interest Expense / Debt = 1.03% (Interest Expense 19.6m / Debt 1.91b)
Taxrate = 21.0% (US default 21%)
NOPAT = -175.9m (EBIT -222.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.09 (Total Current Assets 1.95b / Total Current Liabilities 1.78b)
Debt / Equity = 2.60 (Debt 1.91b / totalStockholderEquity, last quarter 732.3m)
Debt / EBITDA = 15.11 (Net Debt 678.3m / EBITDA 44.9m)
Debt / FCF = 1.10 (Net Debt 678.3m / FCF TTM 619.0m)
Total Stockholder Equity = 906.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -6.01% (Net Income -267.6m / Total Assets 4.62b)
RoE = -29.52% (Net Income TTM -267.6m / Total Stockholder Equity 906.4m)
RoCE = -8.12% (EBIT -222.7m / Capital Employed (Equity 906.4m + L.T.Debt 1.84b))
RoIC = -6.77% (negative operating profit) (NOPAT -175.9m / Invested Capital 2.60b)
WACC = 9.09% (E(13.69b)/V(15.60b) * Re(10.24%) + D(1.91b)/V(15.60b) * Rd(1.03%) * (1-Tc(0.21)))
Discount Rate = 10.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.36%
[DCF Debug] Terminal Value 65.45% ; FCFF base≈408.3m ; Y1≈268.0m ; Y5≈122.3m
Fair Price DCF = 2.68 (EV 2.01b - Net Debt 678.3m = Equity 1.33b / Shares 497.8m; r=9.09% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 77.75 | EPS CAGR: 40.30% | SUE: -0.57 | # QB: 0
Revenue Correlation: 91.07 | Revenue CAGR: 26.53% | SUE: -1.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.26 | Chg30d=-0.012 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=1.59 | Chg30d=-0.023 | Revisions Net=-2 | Growth EPS=+107.9% | Growth Revenue=+21.3%